Animal-specific High-frequency Electrosurgery Device industry trends. Over the past 12‑18 months the sector has accelerated through strategic collaborations and capital influx. In June 2023, Medtronic partnered with veterinary‑focused startup VetTech Innovations to co‑develop a miniaturized HF electrosurgery platform tailored for small‑animal surgeries, promising faster hemostasis and reduced thermal spread. The same quarter, Johnson & Johnson’s subsidiary, DePuy Synthes, completed the acquisition of Swiss‑based MedVet Solutions, expanding its portfolio with patented bipolar technology for equine procedures. Early 2024 saw the launch of the “EcoPulse” series by Olympus, featuring AI‑driven energy modulation that adapts in real time to tissue impedance, a first in the veterinary market. Regulatory momentum followed when the EU updated its Medical Device Regulation (MDR) to include specific veterinary electrosurgical classifications, streamlining approval pathways. Meanwhile, venture capital activity surged, with a $45 million Series B round led by OrbiMed backing a cloud‑connected electrosurgery device platform aimed at large‑scale animal hospitals. These developments signal a shift toward integrated, data‑rich solutions and heightened investment in animal‑centric surgical innovation.